ATE251221T1 - Verfahren zur bestimmung der enzymatischen aktivität des blutkoagulationsfaktors xiii, das gereinigtes fibrinmonomer als substrat verwendet - Google Patents

Verfahren zur bestimmung der enzymatischen aktivität des blutkoagulationsfaktors xiii, das gereinigtes fibrinmonomer als substrat verwendet

Info

Publication number
ATE251221T1
ATE251221T1 AT98929875T AT98929875T ATE251221T1 AT E251221 T1 ATE251221 T1 AT E251221T1 AT 98929875 T AT98929875 T AT 98929875T AT 98929875 T AT98929875 T AT 98929875T AT E251221 T1 ATE251221 T1 AT E251221T1
Authority
AT
Austria
Prior art keywords
blood coagulation
coagulation factor
factor xiii
fibrin monomer
enzymatic activity
Prior art date
Application number
AT98929875T
Other languages
English (en)
Inventor
Hee-Chul Kim
Jae-Wook Huh
Shin-Jae Chang
Jeung-Sik Lee
Soon-Kwan Chung
Hark-Mo Seong
Original Assignee
Green Cross Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Korea filed Critical Green Cross Korea
Application granted granted Critical
Publication of ATE251221T1 publication Critical patent/ATE251221T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G01N2333/91085—Transglutaminases; Factor XIIIq (2.3.2.13)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ecology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT98929875T 1997-06-18 1998-06-16 Verfahren zur bestimmung der enzymatischen aktivität des blutkoagulationsfaktors xiii, das gereinigtes fibrinmonomer als substrat verwendet ATE251221T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019970025516A KR100222292B1 (ko) 1997-06-18 1997-06-18 피브린 단량체를 이용한 혈액 응고 제 13인자의활성 측정방법
PCT/KR1998/000160 WO1998058078A1 (en) 1997-06-18 1998-06-16 Method of determining the enzymatic activity of the blood coagulation factor xiii using purified fibrin monomer as a substrate

Publications (1)

Publication Number Publication Date
ATE251221T1 true ATE251221T1 (de) 2003-10-15

Family

ID=19510077

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98929875T ATE251221T1 (de) 1997-06-18 1998-06-16 Verfahren zur bestimmung der enzymatischen aktivität des blutkoagulationsfaktors xiii, das gereinigtes fibrinmonomer als substrat verwendet

Country Status (7)

Country Link
US (1) US6406874B1 (de)
EP (1) EP0956363B1 (de)
JP (1) JP3193728B2 (de)
KR (1) KR100222292B1 (de)
AT (1) ATE251221T1 (de)
DE (1) DE69818639T2 (de)
WO (1) WO1998058078A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10046187A1 (de) * 2000-09-13 2002-03-21 Univ Schiller Jena Verfahren zur Messung der Aktivität von Gerinnungsfaktor XIIIa
US20070125392A1 (en) * 2005-12-01 2007-06-07 Sdgi Holdings, Inc. Systems and methods of accounting for surgical instruments and disposables
CN113025685A (zh) * 2021-03-25 2021-06-25 哈尔滨瀚邦医疗科技有限公司 一种测定凝血因子xiii活性的方法及其在猪血制品检测中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453359A (en) * 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
DE3834233A1 (de) * 1988-10-07 1990-04-19 Max Planck Gesellschaft Verfahren zur aktivitaetsbestimmung von transglutaminasen
DE4038899C2 (de) * 1990-12-06 1995-01-19 Dempfle Carl Erik Dr Med Verfahren und Reagenzien zur Bestimmung der enzymatischen Aktivität von Transglutaminasen (EC 2.3.2.13)
CA2105863A1 (en) * 1991-03-11 1992-09-12 Guy L. Reed Compositions and methods to inhibit the activation of active factor xiii
JP3224607B2 (ja) * 1992-09-11 2001-11-05 株式会社アズウェル 血液凝固第ｘｉｉｉ因子活性測定方法および該測定用試薬キット
DE4402631A1 (de) * 1994-01-29 1995-08-03 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Gerinnungsparametern
US5464471A (en) * 1994-11-10 1995-11-07 Whalen Biomedical Inc. Fibrin monomer based tissue adhesive

Also Published As

Publication number Publication date
KR100222292B1 (ko) 1999-10-01
EP0956363A1 (de) 1999-11-17
US6406874B1 (en) 2002-06-18
KR19990002006A (ko) 1999-01-15
JP3193728B2 (ja) 2001-07-30
DE69818639T2 (de) 2004-08-05
EP0956363B1 (de) 2003-10-01
WO1998058078A1 (en) 1998-12-23
DE69818639D1 (de) 2003-11-06
JP2000501295A (ja) 2000-02-08

Similar Documents

Publication Publication Date Title
Grinnell et al. Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin)
DE69018910D1 (de) Verfahren zur Bestimmung des endogenen Thrombinpotentials von Plasma und Blut und Reagenziensatz zur Verwendung in besagtem Verfahren.
Sherry et al. Comparative activity of thrombin on substituted arginine and lysine esters
ATE243538T1 (de) Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
DE69735127D1 (de) Enzymsensor
DE3780485D1 (de) Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet.
Aoki et al. Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: new methods for the detection of plasminogen variants
Galanakis et al. Evaluation of the role of in vivo proteolysis (fibrinogenolysis) in prolonging the thrombin time of human umbilical cord fibrinogen
ATE196804T1 (de) Test für thrombosegefahr
DK0690991T4 (da) Ny antikoagulant-cofaktor-aktivitet
ATE251221T1 (de) Verfahren zur bestimmung der enzymatischen aktivität des blutkoagulationsfaktors xiii, das gereinigtes fibrinmonomer als substrat verwendet
Bonilla Defibrinating enzyme from timber rattlesnake (Crotalus H. Horridus) venom: A potential agent for therapeutic defibrination I. Purification and properties
CN111684076A (zh) 纤维蛋白原测试
Sherry et al. Thrombin as a proteolytic enzyme
Meier et al. Snake venom protein C activators
JP4721519B2 (ja) タンパク質分解酵素の生物学的に活性な形態の決定
Szczelik Trypsin-like activity of serum: its origin and electrophoretic separation
Vinazzer Photometric assay of antithrombin III with a chromogenic substrate
JP2002537820A5 (de)
NAKANO et al. Isolation and characterization of four forms of trehalase from rabbit kidney cortex
Arnesen Characterization of fibrinogen and fibrin degradation products by isoelectric focusing in polyacrylamide gel
ES2239388T3 (es) Procedimiento para la deteccion funcional de trastornos en el sistema de la proteina c.
ATE242883T1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix
ATA99992A (de) Verfahren zur bestimmung von fibrinogen
Wolf et al. Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0956363

Country of ref document: EP